[HTML][HTML] Magnetic iron oxide nanoparticles for brain imaging and drug delivery

R Qiao, C Fu, H Forgham, I Javed, X Huang… - Advanced Drug Delivery …, 2023 - Elsevier
Central nervous system (CNS) disorders affect as many as 1.5 billion people globally. The
limited delivery of most imaging and therapeutic agents into the brain is a major challenge …

Applications of focused ultrasound-mediated blood-brain barrier opening

CM Gorick, VR Breza, KM Nowak, VWT Cheng… - Advanced drug delivery …, 2022 - Elsevier
The blood brain barrier (BBB) plays a critically important role in the regulation of central
nervous system (CNS) homeostasis, but also represents a major limitation to treatments of …

Delivering the promise of gene therapy with nanomedicines in treating central nervous system diseases

M Luo, LKC Lee, B Peng, CHJ Choi… - Advanced …, 2022 - Wiley Online Library
Abstract Central Nervous System (CNS) diseases, such as Alzheimer's diseases (AD),
Parkinson's Diseases (PD), brain tumors, Huntington's disease (HD), and stroke, still remain …

Recent advances on ultrasound contrast agents for blood-brain barrier opening with focused ultrasound

A Dauba, A Delalande, HAS Kamimura, A Conti… - Pharmaceutics, 2020 - mdpi.com
The blood-brain barrier is the primary obstacle to efficient intracerebral drug delivery.
Focused ultrasound, in conjunction with microbubbles, is a targeted and non-invasive way to …

Nanomaterials for Parkinson disease: Recent progress

E Ghazy, A Rahdar, M Barani, GZ Kyzas - Journal of Molecular Structure, 2021 - Elsevier
Even though Parkinson's disease (PD) is the second most common neurological disorder
(ND), it faces an absence of credible drug delivery, treatment and diagnosis. Levodopa is …

A novel fluorinated polyethyleneimine with microRNA-942-5p-sponges polyplex gene delivery system for non-small-cell lung cancer therapy

Y Jin, W Yu, W Zhang, C Wang, Y Liu, WE Yuan… - Journal of Colloid and …, 2023 - Elsevier
Gene delivery for non-small-cell lung cancer treatment has been a challenge due to low
nucleic acid binding ability, cell-wall barrier, and high cytotoxicity. Cationic polymers, such …

Mechanistic insights, treatment paradigms, and clinical progress in neurological disorders: current and future prospects

S Alkahtani, NS Al-Johani, S Alarifi - International Journal of Molecular …, 2023 - mdpi.com
Neurodegenerative diseases (NDs) are a major cause of disability and are related to brain
development. The neurological signs of brain lesions can vary from mild clinical shortfalls to …

[HTML][HTML] The relationship between surface drug distribution of Dox-loaded microbubbles and drug release/cavitation behaviors with ultrasound

CW Lin, CH Fan, CK Yeh - Ultrasonics Sonochemistry, 2024 - Elsevier
Abstract Ultrasound (US)-triggered microbubbles (MBs) drug delivery is a promising tool for
noninvasive and localized therapy. Several studies have shown the potential of drug-loaded …

Nanoparticles as drug delivery systems of RNAi in cancer therapy

D Li, C Gao, M Kuang, M Xu, B Wang, Y Luo, L Teng… - Molecules, 2021 - mdpi.com
RNA interference (RNAi) can mediate gene-silencing by knocking down the expression of a
target gene via cellular machinery with much higher efficiency in contrast to other antisense …

Nanoplatform‐based in vivo gene delivery systems for cancer therapy

R Luo, H Le, Q Wu, C Gong - Small, 2024 - Wiley Online Library
Gene therapy uses modern molecular biology methods to repair disease‐causing genes. As
a burgeoning therapeutic, it has been widely applied for cancer therapy. Since 1989, there …